• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchMetsera
    Picture of Metsera logo

    MTSR — Metsera Share News

    $52.990.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapMomentum Trap
    • Market Cap
      $5.58bn
    • Enterprise Value
      $5.05bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • MTSR Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    MTSR Dividends
    • The Week in Breakingviews: Signals in the AI noise

      02/11/2025 23:45
    • Brief: Metsera Disagrees With Allegations In Pfizer's Complaint

      31/10/2025 22:26
    • Brief: Pfizer Files Lawsuit Against Metsera And Its Directors And Novo Nordisk For Breach Of Merger Agreement

      31/10/2025 21:44
    • Pfizer sues Metsera, Novo Nordisk over breach of merger deal

      31/10/2025 20:41
    • Pfizer gets US antitrust clearance for Metsera deal (updated)

      31/10/2025 20:03
    • Pfizer gets US antitrust clearance for Metsera deal

      31/10/2025 19:53
    • Analysis: Pfizer could hold a Trump card in its bid for Metsera

      31/10/2025 10:00
    • Metsera the US obesity biotech at centre of Novo, Pfizer bidding war

      31/10/2025 07:28
    • Press Digest: British Business - October 31

      31/10/2025 02:32
    • Newscasts - Novo Nordisk takes on Pfizer in bid for obesity biotech Metsera

      30/10/2025 19:05
    • Analysis: Novo Nordisk changes tack with bold raid on Pfizer obesity deal

      30/10/2025 17:56
    • U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna

      30/10/2025 17:41
    • Brief: Pfizer Mulls Suing Metsera, Novo Over Topping Bid - Semafor

      30/10/2025 17:37
    • Metsera the US obesity biotech at centre of Novo, Pfizer bidding war

      30/10/2025 16:36
    • Obesity drug developers rise as Metsera receives fresh bid from Novo Nordisk

      30/10/2025 16:07
    • Obesity feeding frenzy risks queasy outcome

      30/10/2025 14:16
    • Deals of the day-Mergers and acquisitions

      30/10/2025 14:02
    • Novo Nordisk says offer for Metsera adheres to restrictions under Pfizer deal

      30/10/2025 13:40
    • U.S. STOCKS ON THE MOVE-Wolfspeed, Carvana, Metsera

      30/10/2025 13:09
    • Metsera jumps as Novo challenges Pfizer in bidding war for obesity drug developer

      30/10/2025 11:19
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.